Publications

<< back

• Jochen Schmitt - Selected publications
  
  Schmitt J, Wozel G, Pfeiffer C (2004)
  Leflunomideas a noveltreatmentoption in severeatopic dermatitis.
  Br J Dermatol 150:1182-5.
  
  Schmitt J, Wozel G (2005)
  The psoriasis area and severity index is the adequate criterion to define severity in chronic plaque-type psoriasis.
  Dermatology 210(3):194-199.
  
  Schmitt J, Ford DE (2006)
  Work limitations and productivity loss are associated with health-related quality of life but not with clinical severity in patients with psoriasis.
  Dermatology 213(2):102-110.
  
  Schmitt J, Schmitt NM, Meurer M (2007)
  Cyclosporin in the treatment of patients with atopic eczema – a systematic review and meta-analysis.
  J EurAcadDermatol 21:606-619.
  
  Schmitt J, Ford DE (2007)
  Role of depression in quality of life for patients with psoriasis.
  Dermatology 215(1):17-27.
  
  Schmitt J, Heese E, Wozel G, Meurer M (2007)
  Effectiveness of in-patient treatment on quality of life and clinical disease severity in atopic dermatitis and psoriasis vulgaris – a prospective study.
  Dermatology 214(1):68-76.
  
  Schmitt J, Ford D (2007)
  Understanding the relationship between objective disease severity, psoriatic symptoms, illness-related stress, health-related quality of life and depressive symptoms in patients with psoriasis - A structional equations modeling approach.
  Gen HospPsych 29(2):134-140.
  
  Schmitt NM, Nicholson WK, Schmitt J (2007)
  The Association of Pregnancy and the Development of Obesity – Results of a Systematic Review and Meta-analysis on the Natural History of Postpartum Weight Retention.
  Int J Obesity 31(11):1642-51.
  
  Schmitt J, Langan S, Williams H (2007)
  What are the best outcome measurements for atopic eczema? -A systematic review.
  J AllergyClin Immun 120:1389-1398.
  
  Schmitt J, Schäkel K, Schmitt NM, Meurer M (2007)
  Systemic Treatment of Severe Atopic Eczema – A Systematic Review.
  ActaDermVenerol 87(2):100-111.
  
  Schmitt J, Meurer M, Klon M, Frick KD (2008)
  Assessment of health state utilities of controlled and uncontrolled psoriasis and atopic eczema – A population-based study.
  Brit J Dermatol 158:351-359.
  
  Schmitt J, Csötönyi F, Bauer A, Meurer M (2008)
  Einflussfaktoren auf Therapieziele und Behandlungszufriedenheit von Patienten mit atopischem Ekzem. [Determinants of treatment goals and satisfaction of patients with atopic eczema]
  JDDG 6(6):458-466.
  
  Schmitt J, Meurer M, Schwanebeck U, Grählert X, Schäkel K (2008)
  Treatment following an evidence-based algorithm versus individualised symptom-oriented treatment treatment for atopic eczema. A randomised controlled trial. Dermatology 217:299-308.
  
  Schmitt J, Zhang Z, Wozel G, Meurer M, Kirch W (2008)
  Efficacy and tolerability of biologic and non-biologic systemic treatments for moderate-to-severe psoriasis: meta-analysis of randomized controlled trials.
  Brit J Dermatol 159:513-526.
  
  Schmitt J, Maywald U, Schmitt N, Meurer M , Kirch W (2008)
  Cardiovascular comorbidity and cardiovascular risk factors in patients with chronic inflammatory skin diseases: A case-control study utilising a population-based administrative database.
  Italian Journal of Public Health, Year 6, 5(3):187-193.
  
  Schmitt J, Schmitt N, Kirch W, Meurer M (2009)
  Ambulante Versorgung und medikamentöse Behandlung von Kindern und Erwachsenen mit Atopischem Ekzem. [Outpatient care and medical treatment of children and adults with atopic eczema]
  JDDG 7(4):345–351.
  
  Schmitt J, Romanos M, Schmitt N, Meurer M, Kirch W (2009)
  Atopic eczema and attention-deficit/hyperactivity disorder in a population-based sample of children and adolescents.
  JAMA 301(7):724-726.
  
  Schmitt J, Kirch W, Meurer M (2009)
  Auswirkungen der Einführung der Praxisgebühr auf die ambulante Versorgung und Therapie von Patienten mit atopischem Ekzem. [Effects of the introduction of the German “Praxisgebühr” on outpatient care and treatment of patients with atopic eczema].
  JDDG 7(10):879–887.
  
  Schmitt J, Schmitt NM, Kirch W, Meurer M (2009)
  Bedeutung des atopischen Ekzems in der ambulanten medizinischen Versorgung. EineSekundärdatenanalyse. [Significance of atopic dermatitis in outpatient medical care. Analysis of health care data from Saxony]
  Hautarzt 60(4):320–327.
  
  Schmitt J, Romanos M, Pfennig A, Leopold K, Meurer M (2009)
  Psychiatric comorbidity in adult eczema.
  Brit J Dermatol 161(4):878–883.
  
  Schmitt J, Wozel G (2009)
  Targeted treatment of psoriasis with Adalimumab: a critical appraisal based on a systematic review of the literature.
  Biologics: Targets and Therapy 3:303–318.
  
  Schmitt J, Schmitt NM, Kirch W, Meurer M (2010)
  Early exposure to antibiotics and infections and the incidence of atopic eczema: A population-based cohort study.
  Pediatric Allergy and Immunology 21(2 Pt 1):292-300.
  
  Romanos M, Gerlach M, Warnke A, Schmitt J (2010)
  Association of attention-deficit/hyperactivity disorder and atopic eczema modified by sleep disturbance in a large population-based sample.
  JournalofEpidemiologyandCommunity Health64(3):269-273.
  
  Schmitt J, Apfelbacher C, Chen C, Romanos M, Sausenthaler S, Koletzko S, Bauer CP, Hoffmann U, Krämer U; Berdel D, Berg A, Wichmann HE, Heinrich J, (GINIplus) (2010)
  Infant-onset eczema in relation to mental health problems at age 10 years: Results from a prospective birth cohort study (German Infant Nutrition Intervention plus)
  JACI 125(2):404-410.
  
  Schmitt J, Schäkel K, Fölster-Holst R, Bauer A, Oertel R, Augustin M, Aberer W, Luger T, Meurer M (2010)
  Prednisolone vs. ciclosporin for severe adult eczema.An investigator-initiated double-blind placebo-controlled multicentre trial.
  British Journal of Dermatology 162(3):661-668.
  
  Schmitt J, Ford D (2010)
  Psoriasis is independently associated with psychiatric morbidity and adverse cardiovascular risk factors, but not with cardiovascular events in a population-based sample.
  J EurAcadDermatol 24(8):885–892.
  
  Schmitt J, Diepgen TL, Bauer A (2010)
  Berufliche Exposition gegenüber UV-Strahlung und nicht-melanozytärer Hautkrebs – Systematisches Review zur Frage einer neuen Berufskrankheit. [Occupational exposure to non-artificial UV-light and non-melanocytic skin cancer – a systematic review concerning a new occupational disease]
  JDDG 8(4):250-63.
  
  Schmitt J, Buske-Kirschbaum A, Roessner V (2010)
  Is atopic disease a risk factor for attention-deficit/hyperactivity disorder? A systematic review.
  Allergy 65(12):1506-24.
  
  Schmitt J, Chen CM, Apfelbacher C, Romanos M, Lehmann I, Herbarth O, Schaaf B, Kraemer U, von Berg A, Wichmann HE, Heinrich J and the LISA-plus Study Group (2011)
  Infant eczema, infant sleeping problems, and mental health at 10 years of age: the prospective birth cohort study LISAplus.
  Allergy66(3):404-411.
  
  Apfelbacher C, Diepgen TL, Schmitt J (2011)
  Determinants of eczema: population-based cross-sectional study in Germany.
  Allergy66(2):206-13.
  
  Schmitt J, Langan S, StammT, Williams H(2011)
  Core outcome domains for controlled trials and clinical recordkeeping in eczema: International multi-perspective Delphi consensus process.
  Journal of Investigative Dermatology 131(1):623-630.
  
  Schmitt J, von Kobyletzki L, Svensson A, Apfelbacher C (2011)
  Efficacy and tolerability of proactive treatment with topical corticosteroids and calcineurin-inhibitors for atopic eczema: systematic review and meta-analysis of randomised controlled trials.
  British Journal of Dermatology 164(2):415-28.
  
  Schmitt J, Seidler A, Diepgen TL, Bauer A (2011)
  Occupational ultraviolet light exposure increases the risk for the development of cutaneous squamous cell carcinoma: a systematic review and meta-analysis.
  British Journal of Dermatology164(2):291–307.
  
  Schmitt J, Seidler A, Heinisch G, Sebastian G (2011)
  Effektivität des Hautkrebsscreenings für die Altersgruppe der 14- bis 34-Jährigen – Ergebnisse eines Modellvorhabens aus Sachsen. [Effectiveness of skin cancer screening for individuals age 14 to 34 years]
  JDDG 9(8):608–617.
  
  Lorenz M, Wozel G, Schmitt J (2012)
  Hypersensitivity Reactions to Dapsone: A Systematic Review.
  Acta DermVenereol 92(2):194–199.
  
  Schmitt J, Apfelbacher C, Flohr C (2011)
  Eczema
  BMJ Clinical Evidence (published online) pii:1716.
  
  Bauer A, Diepgen TL, Schmitt J (2011)
  Is occupational solar ultraviolet irradiation a relevant risk factor for basal cell carcinoma? A systematic review and meta-analysis of the epidemiological literature
  British Journal of Dermatology 165(3):612–625.
  
  Müller H, Rehberger P, Günther C, Schmitt J (2012)
  Determinants of disability, quality of life and depression in dermatological patients with systemic scleroderma.
  Brit J Dermatol 166(2):343–353.
  
  Schram ME, Spuls PI, Leeflang MMG, Lindeboom R, Bos JD, Schmitt J (2012)
  EASI, (objective) SCORAD and POEM for atopic eczema: responsiveness and minimal clinically important difference.
  Allergy 67(1):99–106.
  
  Weberschock, T, Strametz, R, Lorenz, M, Röllig, C, Bunch, C, Bauer, A, Schmitt, J (2012)
  Interventions for mycosis fungoides
  Cochrane database of systematic reviews; 9, CD008946 DOI: 10.1002/14651858.CD008946.pub2
  
  Schmitt J, Romanos M (2012)
  Pre- and Perinatal Risk Factors for Attention-Deficit/Hyperactivity Disorder.
  Archives of Pediatrics & Adolescent Medicine 166(11):1074-1075.
  
  Schmitt J, Spuls P, Boers M, Thomas K, Chalmers J, Roekevisch E, Schram M, Allsopp R, Aoki V, Apfelbacher C, Bruijnzeel-Koomen C, Bruin-Weller M, Charman C, Cohen A, Dohil M, Flohr C, Furue M, Gieler U, Hooft L, Humphreys R, Ishii HA, Katayama I, Kouwenhoven W, Langan S, Lewis-Jones S, Merhand S, Murota H, Murrell DF, Nankervis H, Ohya Y, Oranje A, Otsuka H, Paul C, Rosenbluth Y, Saeki H, Schuttelaar M-L, Stalder J-F, Svensson A, Takaoka R, Wahlgren C-F, Weidinger S, Wollenberg A, Williams H (2012)
  Towards global consensus on outcome measures for atopic eczema research: results of the HOME II meeting.
  Allergy67(9):1111-7.
  
  Schmitt J, Apfelbacher C, Heinrich J, Weidinger S, Romanos M (2013)
  Assoziation von Neurodermitis und Aufmerksamkeits-Defizit/Hyperaktivitäts-Syndroms - Meta-Analyse aktueller epidemiologischer Studien. [Association of atopic eczema and attention-deficit/hyperactivity disorder - Meta-analysis of epidemiologic studies.]
  Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie 41(1):35-44.
  
  Spornraft-Ragaller P, Kämmerer E, Gillitzer C, Schmitt J (2012)
  Schwere allergische Reaktion auf Para-Phenylendiamin bei Kindern und Jugendlichen: Muss die Test-Konzentration von PPD angepasst werden? [Severe allergic reactions to para-phenylenediamine in children and adolescents: should the patch test concentration of PPD be changed?]
  JDDG 10(4):258-63.
  
  Rehberger P, Günther C, Müller H, Schmitt J (2012)
  Behandlungszufriedenheit und Versorgungsstatus bei Patienten mit systemischer Sklerodermie. [Treatment satisfaction and health status in patients with systemic sclerosis]
  J DtschDermatol Ges. 10(12):905-912.
  
  Diepgen, TL, Drexler, H, Schmitt, J (2012)
  Epidemiologieberufsbedingter UV-abhängigerHauttumoren [Epidemiology of occupational skin cancer due to UV-irradiation]
  Hautarzt 63(10):769-77.
  
  Schmitt J (2012)
  Wie werden Patienten mit atopischem Ekzem tatsächlich versorgt? Eine Sekundärdatenanalyse von Routinedaten der Gesetzlichen Krankenversicherung.
  Allergo Journal 21 (7):418-424.
  
  Schnetz E, Kuss O, Schmitt J, Diepgen TL, Kuhn M, Fartasch M (1999)
  Intra- and inter-individual variations in transepidermal water loss on the face: facial locations for bioengineering studies.
  Contact Dermatitis 40(5):243-247.
  
  Dickel H, Kuss O, Schmidt A, Schmitt J, Diepgen TL (2001)
  Inzidenz berufsbedingter Hautkrankheiten in hautgefährdenden Berufsordnungsgruppen. [Incidence of occupational skin diseases in occupational groups]
  Hautarzt 52(7):615-623.
  
  Zhang Z, Schmitt J, Wozel G, Kirch W (2009)
  Behandlung der Plaque-Psoriasis mit Biologics. Eine Metaanalyse randomisierter kontrollierter Studien. [Treatment of plaque psoriasis with biologics. A meta-analysis of randomized controlled trials]
  Med Klin (Munich) 104(2):125-36
  
  Langan S, Schmitt J, Coenraads PJ, Svensson A, Elm E, Williams HC on behalf of EDEN, UK (2010)
  The reporting of observational research studies in dermatology journals: a literature-based study.
  Arch Dermatol. 146(5):534-41
  
  Bauer A, Schmitt J, Bennett C, Coenraads PJ, Elsner P, English J, Williams HC (2010)
  Interventions for preventing occupational irritant hand dermatitis.
  Cochrane Database Syst Rev. 6:CD004414.
  
  Singh JA, Wells GA, Christensen R, TanjongGhogomu E, Maxwell L, Macdonald JK, Filippini G, Skoetz N, Francis D, Lopes LC, Guyatt GH, Schmitt J, La Mantia L, Weberschock T, Roos JF, Siebert H, Hershan S, Lunn MP, Tugwell P, Buchbinder R. (2011)
  Adverse effects of biologics: a network meta-analysis and Cochrane overview.
  Cochrane Database Syst Rev. 2:CD008794.
  
  Apfelbacher C, Akst W, Molin S, Schmitt J, Bauer A, Weisshaar E, Mahler V, Treichel S, Ruzicka T, Luger T, Elsner P, Diepgen TL (2011)
  CARPE: ein Registerprojekt der Deutschen Dermatologischen Gesellschaft (DDG) zur Charakterisierung und Versorgung des chronischen Handekzems. [CARPE: a registry project of the German Dermatological Society (DDG) for the characterization and care of chronic hand eczema]
  JDDG 9(9):682-8.
  
  Aschoff R, Schmitt J, Knuschke P, Koch E, Bräutigam M, Meurer M (2011)
  Evaluation of the atrophogenic potential of hydrocortisone 1% cream and pimecrolimus 1% cream in uninvolved forehead skin of patients with atopic dermatitis using optical coherence tomography.
  Experimental Dermatology 20(10):832-6.
  
  Weberschock T, Meister AC, Bohrt K, Schmitt J, Boehncke WH, Ludwig RJ (2011)
  The risk for cross-reactions after a cutaneous delayed-type hypersensitivity reaction to heparin preparations is independent of their molecular weight: a systematic review.
  Contact Dermatitis 65(4):187–194.
  
  Matterne U, Schmitt J, Diepgen TL, Apfelbacher C (2011)
  Children and adolescents’ health-related quality of life in relation to eczema, asthma and hay fever: results from a population-based cross-sectional study
  Qual Life Res 20(8):1295–1305.
  
  Schram ME, Roekevisch E, Leeflang MMG, Bos JD, Schmitt J, Spuls PI (2011)
  A randomized trial of methotrexate versus azathioprine for severe atopic eczema.
  Journal of Allergy and Clinical Immunology 128(2):353-9.
  
  Lucka T, Pathirana D, Sammain A, Bachmann F, Rosumeck S, Erdmann R, Schmitt J,Orawa H, Rzany B, Nast A (2012)
  Efficacy of systemic therapies for moderate-to-severe psoriasis: a systematic review and meta-analysis of long-term treatment.
  J EurAcadDermatolVenereol. 26(11):1331-44.
  
  Buske-Kirschbaum A, Schmitt J, Plessow F, Romanos M, Weidinger S, Roessner V (2013)
  Psychoendocrine and psychoneuroimmunological mechanisms in the comorbidity of atopic eczema and attention deficit/hyperactivity disorder
  Psychoneuroendocrinology 38(1):12–23.
  
  Schreckenberg, D, Eikmann, T, Guski, R, Klatte, M, Müller, U, Peschel, C, Schmitt, J, Seidler, A, Möhler, U (2012)
  NORAH (Noise-RelatedAnnoyance, Cognition, andHealth) – Konzept einer Studie zur Wirkung von Verkehrslärm bei Anwohnern von Flughäfen
  Lärmbekämpfung, 6(3),107-114.
  
  Dickel H, Kuss O, Schmidt A, Schmitt J, Diepgen TL (2001)
  Auswertung abschließend beurteilter Berufskrankheiten-Anzeigen in Nordbayern zwischen 1990 und 1999.
  Dermatol Beruf Umwelt 49:26.
  
  Günther HC, Schmitt J, Wozel G (2004)
  Erfolgreicher Einsatz von Fumarsäureestern bei einer 14-jährigen Patientin mit Psoriasis vulgaris.
  Haut 15(1):28-30.
  
  Schmitt J, Wozel G (2004)
  Psoriasis-Arthritis – Langzeittherapie zweier Patienten mit Leflunomid. [Psoriasis arthritis--long-term treatment of two patients with leflunomide]
  JDDG 2(9):763-6.
  
  Schmitt J, Stoller S, Wozel G (2005)
  Alefacept: Erfolgreiche Langzeittherapie einer schweren Psoriasis. [Alefacept. Successful long-term therapy of a severe psoriasis]
  Hautarzt 56(4):360-2.
  
  Eppinger S, Schmitt J, Meurer M (2006)
  Morbus Reiter oder reaktive Arthritis – darf eine Krankheit nach einem NS-Funktionär benannt werden? [Reiter diseaseorreactivearthritis?]
  Hautarzt 57(4):336-339.
  
  Rehberger P, Eppinger S, Stein A, Schmitt J (2006)
  Therapie von Hautmetastasen beim malignen Melanom. [Therapy of cutaneous metastases of malignant melanoma]
  Hautarzt 57(12):1143–1153.
  
  Schmitt J, Meurer M (2006)
  Topische Kombinationstherapien bei Psoriasis: Stellenwert von Calcitriol und Vitamin D-Analoga. [Combined topical therapy of psoriasis: position of calcitriol and vitamin D analogs]
  Hautarzt 57(8):679–684.
  
  Schmitt NM, Schmitt J, Kirch W (2007)
  Aktuelle Aspekte zum Nikotinkonsum der Mutter während und nach der Schwangerschaft.
  Public Health Forum 15(54): 31-32.
  
  Eppinger S, Schmitt J, Scholz A, Meurer M (2007)
  Zur Erinnerung an die in der Zeit des Nationalsozialismus ermordeten und durch Suizid aus dem Leben geschiedenen jüdischen Dermatologen aus Deutschland. [In memory of our Jewish colleagues who were murdered or committed suicide during the National Socialist Era]
  Hautarzt 58(1):94-95.
  
  Schmitt J (2007)
  Systemic anti-inflammatory therapies for atopic eczema.Invited commentary.National Knowledge Week on Atopic Eczema.[http://stage.library.nhs.uk/skin/Page.aspx?pagename=ECZEMASCHM] 11.09.2008.
  The UK National Library for Health.
  
  Schmitt NM, Schmitt J, Kirch W (2007)
  Review on Determinants Interactions between Nutrition and Physical Activity.
  Working Party on Information on Lifestyle and Specific Subpopulations - Newsletter 2(3):4-6.
  
  Schmitt J, Schäkel K (2007)
  Omalizumab als therapeutische Alternative beim atopischen Ekzem. [Omalizumab as a therapeutic option in atopic eczema. Current evidence and potential benefit]
  Hautarzt 58(2):128-132.
  Schmitt NM, Schmitt J, Kouimintzis DJ, Kirch W (2007)
  Health risks in tobacco farmworkers – A review of the literature.
  J Public Health 15:255-264.
  
  Schmitt NM, Schmitt J, Kirch W (2008)
  Sozioökonomische Ungleichheiten in der Gesundheit und im Gesundheitsverhalten. Aktuelle Entwicklungen in Deutschland und Europa.
  Wissenschaftl Z TU Dresden 57:77-80.
  
  Bär M, John L, Wonschik S, Schmitt J, Kempter W, Bauer A, Meurer M (2008)
  Acute generalized exanthematouspustulosis induced by prednisolone in a female suffering from multiple sclerosis.
  Acute generalized exanthematouspustulosis induced by high-dose prednisolone in a young woman with optic neuritis owing to disseminated encephalomyelitis
  Brit J Dermatol 159(1):251-252.
  
  Bär M, Schmitt J, Bauer A, Wozel G, Meurer M (2008)
  Successful treatment of an elderly patient with refractory UVA-sensitive atopic eczema with mycophenolic acid.
  Acta DermVenerol 88(4):404-405.
  
  Schmitt J, Bauer A, Meurer M (2008)
  Das Atopische Ekzem im Erwachsenenalter. [Atopicexzema in adulthood]
  Hautarzt 59(10):841-852.
  
  Schmitt J (2008)
  What is the role of exclusive breastfeeding as a primary prevention strategy for atopic eczema? Invited commentary.National Knowledge Week on Atopic Eczema.[http://www.library.nhs.uk/skin/page.aspx?pagename=ECZEMASCHM] 16.09.2008.
  The UK National Library for Health.
  
  Schmitt J, Romanos M (2009)
  Lack of studies investigating the association of childhood eczema, sleeping problems, and attention-deficit/hyperactivity disorder.
  Pediatric Allergy and Immunology 20(3):299-300.
  
  Schmitt J (2009)
  Determinanten aktiver Gesundheitsförderung.
  Prävention und Gesundheitsförderung 4:225–226.
  
  Schmitt NM, Schmitt J, Dören M (2009)
  The role of physical activity in the prevention of osteoporosis in postmenopausal women - an update.
  Maturitas 63(1):34-38.
  
  
  Schmitt J (2010)
  Medizinische Versorgung und gesundheitsökonomische Relevanz der Neurodermitis. [Medical care and health-economic relevance of atopic eczema]
  Allergologie 33(6):279-88.
  
  Schmitt J, Williams HC on behalf of the HOME development group (2010)
  Harmonising Outcome Measures for Eczema (HOME). Report from the first international consensus meeting (HOME 1), 24 July 2010, Munich, Germany.
  British Journal of Dermatology 163(6):1166-8.
  
  Taurines R, Schmitt J, Renner T, Conner AC, Warnke A, Romanos M (2010)
  Developmental comorbidity in attention-deficit/hyperactivity disorder.
  AttenDefHypDisord 2(4):267–289.
  
  Schmitt J (2011)
  Versorgungsforschung am Beispiel Neurodermitis. [Healthservicesresearchtheexampleofatopicdermatitis]
  Hautarzt 62(3):178-188.
  
  Langan SM, Schmitt J, Coenraads PJ, Svensson A, von Elm E, Williams HC;
  European Dermato-Epidemiology Network (EDEN). (2011)
  STROBE and reporting observational studies in dermatology.
  British Journal of Dermatology 164(1):1-3.
  
  Schmitt J, Flohr C, Williams HC (2012)
  Outcome Measures, Case Definition, and Nomenclature Are All Important and Distinct Aspects of Atopic Eczema: A Call for Harmonization.
  J InvestDermatol 132(2):473-474.
  
  Schmitt J (09/2011)
  Commentary: eczema and cancer risk.
  Brit J Dermatol 165(3):463–464.
  
  Schmitt J, Spuls P, Williams H (2011)
  The Harmonizing outcome measures for Eczema (HOME) initiative
  PloS One (online publication, comment) http://www.plosone.org/annotation/listThread.action?inReplyTo=info%3Adoi%2F10.1371%2Fannotation%2F4212a680-e836-4b24-abaf-19c74915e5d6&root=info%3Adoi%2F10.1371%2Fannotation%2F4212a680-e836-4b24-abaf-19c74915e5d6
  
  Schmitt J, Bauer A, Seidler A, Diepgen TL (2011)
  Berufliche UV-Exposition als Risikofaktor für nichtmelanozytären Hautkrebs – epidemiologische Evidenz zur Frage einer neuen Berufskrankheit
  Dermatologie in Beruf und Umwelt 59(2):50-54.
  
  Romanos M, Buske-Kirschbaum A, Fölster-Holst R, Gerlach M, Weidinger S, Schmitt J (2011)
  Itches and scratches – is there a link between eczema, ADHD, sleep disruption and food hypersensitivity?
  Allergy 66(11):1407–1409.
  
  Schmitt J, Bauer A, Meurer M (2011)
  Was tun, wenn Erwachsene am atopischen Ekzem leiden?
  Ästhetische Dermatologie 4(3):33-40.
  
  Schmitt J, Abraham S (2011)
  Atopisches Ekzem. Versorgungsrelevanz, Diagnostik und Therapie im Überblick.
  Der Hausarzt 19:45-50.
  
  Romanos M, Schmitt J (2012)
  Atopisches Ekzem und ADHS.
  MMW Fortschr 154(8):52-3.
  
  Fartasch M, Diepgen TL, Schmitt J, Drexler H (2012)
  Zusammenhang von beruflich bedingter Sonnenexposition und hellem Hautkrebs.
  [The Relationship between occupational sun exposure and non-melanoma skin cancer.]
  DÄB; 109(43):715-20.
  
  Schram ME, Roekevisch E, Leeflang MM, Bos JD, Schmitt J, Spuls PI (2012)
  Response to a randomized trial of methotrexate vs. azathioprine for severe atopic eczema: a critical appraisal.
  Br J Dermatol. 166(4):704.
  
  Diepgen TL, Fartasch M, Drexler H, Schmitt J (2012)
  Occupational Skin Cancer induced by UV-radiation and its prevention.
  Br J Dermatol. 167 Suppl 2:76-84.
  
  Nast A, Schmitt J (2012)
  Comment on Physician Global Assessment (PGA) and Psoriasis Area and Severity Index (PASI): Why do both? A systematic analysis of randomized controlled trials of biologic agents for moderate to severe plaque psoriasis
  JAAD 66(3):369–375.
  
  Drexler, H, Diepgen, TL, Schmitt, J, Schwarz, T, Letzel, S (2012)
  Arbeitsbedingte UV-Exposition und Malignome der Haut
  Dermatologie in Beruf und Umwelt 60:48–55
  
  Schmitt J, Deckert S (2012)
  Systemische Sklerodermie – Herausforderungen für eine fächerübergreifende Behandlung
  JDDG 10(12):873-874.